Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to sugar-free chewing gum with carbamide and plaque acid neutralisation. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food that is the subject of the health claim is sugar-free chewing gum with carbamide. A claim on sugar-free chewing gum and plaque acid neutralisation has already been assessed with a favourable outcome. From the proposed wordings, the Panel assumes that the claim refers to an effect of sugar-free chewing gum with carbamide on plaque acid neutralisation beyond the well established effect that other sugar-free chewing gums (i.e. without carbamide) have on plaque acid neutralisation. The Panel considers that sugar-free chewing gum with carbamide and the comparison food, sugar-free chewing gum without carbamide, are both sufficiently characterised in relation to the claimed effect. The claimed effect is “improved plaque acid neutralisation”. The target population is assumed to be the general population. The Panel considers that plaque acid neutralisation is a beneficial physiological effect. In weighing the evidence, the Panel took into account that the use of sugar-free chewing gum with carbamide after a sugar challenge consistently increased plaque pH compared to sugar-free chewing gums without carbamide, that the pH raising effect correlated positively with the urea content of the gum, and that the mechanism for the effect is well established. On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the use of sugar-free chewing gum with carbamide and plaque acid neutralisation, over and above the effect achieved with sugar-free chewing gums without carbamide. The Panel considers that, in order to obtain the claimed effect, sugar-free chewing gum containing carbamide (at least 20 mg carbamide per piece) should be used for at least 20 minutes after eating or drinking. The target population is the general population. The use of chewing gum should be avoided in children less than three years of age because of a high choking hazard.

Scientific Opinion on the substantiation of health claims related to sugar-free chewing gum with carbamide and plaque acid neutralisation (ID 1153) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 / C.V. Agostoni, J.L. Bresson, S. Fairweather Tait, A. Flynn, I. Golly, H. Korhonen, P. Lagiou, M. Løvik, R. Marchelli, A. Martin, B. Moseley, M. Neuhäuser Berthold, H. Przyrembel, S. Salminen, Y. Sanz, S. Strain, S. Strobel, I. Tetens, D. Tomé, H. van Loveren, H. Verhagen. - In: EFSA JOURNAL. - ISSN 1831-4732. - 9:4(2011 Apr), pp. 2071.1-2071.14. [10.2903/j.efsa.2011.2071]

Scientific Opinion on the substantiation of health claims related to sugar-free chewing gum with carbamide and plaque acid neutralisation (ID 1153) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

C.V. Agostoni
Primo
;
2011

Abstract

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to sugar-free chewing gum with carbamide and plaque acid neutralisation. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food that is the subject of the health claim is sugar-free chewing gum with carbamide. A claim on sugar-free chewing gum and plaque acid neutralisation has already been assessed with a favourable outcome. From the proposed wordings, the Panel assumes that the claim refers to an effect of sugar-free chewing gum with carbamide on plaque acid neutralisation beyond the well established effect that other sugar-free chewing gums (i.e. without carbamide) have on plaque acid neutralisation. The Panel considers that sugar-free chewing gum with carbamide and the comparison food, sugar-free chewing gum without carbamide, are both sufficiently characterised in relation to the claimed effect. The claimed effect is “improved plaque acid neutralisation”. The target population is assumed to be the general population. The Panel considers that plaque acid neutralisation is a beneficial physiological effect. In weighing the evidence, the Panel took into account that the use of sugar-free chewing gum with carbamide after a sugar challenge consistently increased plaque pH compared to sugar-free chewing gums without carbamide, that the pH raising effect correlated positively with the urea content of the gum, and that the mechanism for the effect is well established. On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the use of sugar-free chewing gum with carbamide and plaque acid neutralisation, over and above the effect achieved with sugar-free chewing gums without carbamide. The Panel considers that, in order to obtain the claimed effect, sugar-free chewing gum containing carbamide (at least 20 mg carbamide per piece) should be used for at least 20 minutes after eating or drinking. The target population is the general population. The use of chewing gum should be avoided in children less than three years of age because of a high choking hazard.
Chewing gum ; sugar-free ; carbamide ; plaque acid neutralisation ; health claims
Settore MED/49 - Scienze Tecniche Dietetiche Applicate
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/176723
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact